1.

The National Task Force on COVID-19 recently decided against using which drug in clinical management protocols?

Answer» The National Task Force on COVID-19 recently decided against using Itolizumab in clinical management protocols. The Drugs Controller General of India (DCGI) had earlier approved for "restricted emergency use" of the drug.


Discussion

No Comment Found